Health

2023-06-12 12:44:06



The Department of Dordogne is committed to reducing endocrine disruptors in its territory – Health Environment Network HAUT
1688675888
#Dordogne #Department #committed #reducing #endocrine #disruptors #territory

2023-07-06 19:34:34

Swiss Stan Wawrinka went back in time to present a strong performance in his victory over Argentine Thomas Echeverri, to book a seat in the third round of the Wimbledon Tennis Championships, on Thursday.

The 38-year-old’s career may have been nearing its end, but he outlasted a player a decade and a half younger than him 6-3 4-6 6-4 6-2 in sunny conditions on Court 3.

This is the first time that Wawrinka has reached the third round of a Grand Slam tournament in 3 years, and he will face defending champion Novak Djokovic, who the Swiss beat in the 2015 French Open final.

Wawrinka, ranked 88 in the world and who suffered from problems in his knees that did not prevent him from completing his career, had been eliminated in the first or second round in the last 6 participations in the four major tournaments.

“It’s been a long time since I didn’t win many grand slams,” the player, who won the 2014 Australian Open, the French Open the following year and the 2016 US Open, said in a courtside interview following overcoming the 29th seed at the tournament. I am happy with my performance.”

And Wimbledon is not the favorite tournament for the Swiss player, who reached the quarter-finals on only two occasions, and qualified for the third round at the All England Club for the first time since 2015.

Tough confrontation

Djokovic, seeking to win the tournament for the fifth time in a row and the eighth time in total to equal the record set by Roger Federer, surpasses the head-to-head record once morest Wawrinka with 20 victories once morest 6 defeats, but they did not face each other on grass courts.

“I’d enjoy the fight if he didn’t crush me,” Wawrinka said regarding facing Djokovic, who has only lost twice at Wimbledon since 2013 and had to withdraw due to injury. And I’ll be competitive. I’ll do my best and we’ll see what happens.”

For Wawrinka to stand a chance of preventing Djokovic from winning his 24th Grand Slam title at the All England Club, he will need his arsenal of strikes, especially his signature backhand.

That strike played a major role in taming Djokovic in the 2015 French Open final and the 2016 US Open final, when he delivered a strong performance in 3 sets.

His backhand and forehand were good on Thursday, but experience was the deciding factor as he manipulated his opponent around the court.

Wawrinka’s level fell briefly in the second set, but following breaking serve at 3-3 in the third, he took control of the match.

1688675043
#Wimbledon #Wawrinka #sets #date #Djokovic

2023-07-06 12:43:00

AFP news agency Reporting from Geneva Switzerland on July 6 that Dr. Tedros Adhanom Ghebreyesus, Director of the WHO, said that malaria is still a disease that kills people. The most people in Africa And it kills nearly 500,000 children under five every year.

The “RTS, S” or “Mosquirix” vaccine (RTS, S/Mosquirix), developed by UK’s GlaxoSmithKline (GSK) It was distributed to more than 1.7 million children in three African countries – Ghana, Kenya and Malawi – as part of a pilot programme.

“This vaccine has been proven to be safe and effective. resulting in severe malaria And the number of child deaths has dropped dramatically,” Dr. Tedros added.

“As the first vaccine once morest #malariathe RTS,S vaccine has now been delivered to more than 1.6 million children in Ghana, Kenya and Malawi.

It has been shown to be safe and effective, resulting in a substantial reduction in severe malaria and a fall in child deaths.

Other…

— World Health Organization (WHO) (@WHO) July 5, 2023

In addition to the above three countries which will continue to be vaccinated The other nine African countries are Benin, Burkina Faso, Burundi, Cameroon, and the Democratic Republic of the Congo. (DR Congo), Liberia, Niger, Sierra Leone and Uganda will also receive the malaria vaccine. The first batches of the vaccine are expected to arrive in these countries in the last quarter of 2023 and will be available in early 2024.

What’s more, Dr Tedros said the second malaria vaccine, or “R21/Matrix-M” (R21/Matrix-M), developed by the University of Oxford and produced by the Serum Institute of India (SII), pending pre-qualification by the WHO. to make sure Health products shipped to low-income countries. It is safe and effective.

The WHO, UNICEF and Gavi jointly estimate that Global demand for malaria vaccine might reach 40-60 million doses per year by 2026 and 80-100 million doses per year by 2030.

Photo credit: AFP

1688673983
#deliver #million #doses #malaria #vaccine #African #countries